# Zomedica Corp.: filings

ZOMDF · OTC · CIK 1684144 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/zomdf.md) · [Financials](/companies/zomdf/financials.md) · [Filings](/companies/zomdf/filings.md) · [Insiders](/companies/zomdf/insiders.md)

## Reports and events: 176 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 148, 8-K 114, 10-Q 26, 3 25, DEFA14A 19, 424B5 10, DEF 14A 10, 10-K 9, 4/A 9, CORRESP 9, UPLOAD 9, D 8, EFFECT 7, S-1/A 7, SC 13G 7, 424B3 6, S-8 6, SC 13G/A 6, 424B4 5, CT ORDER 4, ARS 3, PRE 14A 3, S-1 3, S-3/A 3, 8-K/A 2, FWP 2, POS AM 2, S-3 2, SC 13D 2, SC 13D/A 2, 10-K/A 1, 25-NSE 1, 425 1, 8-A12B 1, 8-A12G 1, CERTNYS 1, DEL AM 1, DRS 1, DRS/A 1, DRSLTR 1, S-4 1, S-4/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-05 | 16:30 ET | [8-K](/filings/0001654954-26-007306.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001654954-26-007306 |
| 2026-08-05 | 16:06 ET | [10-Q](/filings/0001104659-26-091075.md) | Quarterly report, period 2026-06-30 | 0001104659-26-091075 |
| 2026-06-11 | 16:15 ET | [8-K](/filings/0001654954-26-005904.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001654954-26-005904 |
| 2026-05-06 | 16:53 ET | [8-K](/filings/0001654954-26-004419.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001654954-26-004419 |
| 2026-05-06 | 16:05 ET | [10-Q](/filings/0001104659-26-056236.md) | Quarterly report, period 2026-03-31 | 0001104659-26-056236 |
| 2026-04-27 | 19:52 ET | [DEF 14A](/filings/0001654954-26-003929.md) | Proxy statement, period 2026-04-24 | 0001654954-26-003929 |
| 2026-03-16 | 16:21 ET | [8-K](/filings/0001654954-26-002304.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001654954-26-002304 |
| 2026-03-16 | 16:06 ET | [10-K](/filings/0001104659-26-028450.md) | Annual report, period 2025-12-31 | 0001104659-26-028450 |
| 2025-11-04 | 16:25 ET | [8-K](/filings/0001654954-25-012575.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001654954-25-012575 |
| 2025-11-04 | 16:06 ET | [10-Q](/filings/0001104659-25-106266.md) | Quarterly report, period 2025-09-30 | 0001104659-25-106266 |
| 2025-08-06 | 16:56 ET | [8-K](/filings/0001654954-25-009136.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001654954-25-009136 |
| 2025-08-06 | 16:03 ET | [10-Q](/filings/0001558370-25-010512.md) | Quarterly report, period 2025-06-30 | 0001558370-25-010512 |
| 2025-06-11 | 16:13 ET | [8-K](/filings/0001654954-25-006839.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001654954-25-006839 |
| 2025-05-15 | 16:12 ET | [8-K](/filings/0001654954-25-005749.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001654954-25-005749 |
| 2025-05-15 | 16:05 ET | [10-Q](/filings/0001558370-25-007874.md) | Quarterly report, period 2025-03-31 | 0001558370-25-007874 |
| 2025-04-30 | 16:35 ET | [DEF 14A](/filings/0001654954-25-004889.md) | Proxy statement, period 2025-04-30 | 0001654954-25-004889 |
| 2025-04-30 | 12:40 ET | [8-K](/filings/0001654954-25-004863.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001654954-25-004863 |
| 2025-03-14 | 18:59 ET | [8-K](/filings/0001654954-25-002744.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001654954-25-002744 |
| 2025-03-13 | 16:03 ET | [10-K](/filings/0001558370-25-002904.md) | Annual report, period 2024-12-31 | 0001558370-25-002904 |
| 2025-03-05 | 20:33 ET | [8-K](/filings/0001654954-25-002296.md) | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001654954-25-002296 |
| 2024-12-19 | 16:30 ET | [8-K](/filings/0001654954-24-015750.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001654954-24-015750 |
| 2024-11-19 | 17:03 ET | [8-K](/filings/0001654954-24-014663.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001654954-24-014663 |
| 2024-11-08 | 13:39 ET | [8-K](/filings/0001654954-24-014016.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001654954-24-014016 |
| 2024-11-07 | 16:06 ET | [10-Q](/filings/0001558370-24-014859.md) | Quarterly report, period 2024-09-30 | 0001558370-24-014859 |
| 2024-08-14 | 17:01 ET | [8-K](/filings/0001654954-24-010666.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001654954-24-010666 |
| 2024-08-14 | 16:58 ET | [8-K](/filings/0001654954-24-010665.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001654954-24-010665 |
| 2024-08-14 | 16:07 ET | [10-Q](/filings/0001558370-24-012228.md) | Quarterly report, period 2024-06-30 | 0001558370-24-012228 |
| 2024-06-07 | 15:54 ET | [8-K](/filings/0001654954-24-007515.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001654954-24-007515 |
| 2024-05-09 | 16:17 ET | [8-K](/filings/0001654954-24-005886.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001654954-24-005886 |
| 2024-05-09 | 16:05 ET | [10-Q](/filings/0001558370-24-007597.md) | Quarterly report, period 2024-03-31 | 0001558370-24-007597 |
| 2024-04-26 | 08:01 ET | [DEF 14A](/filings/0001654954-24-005061.md) | Proxy statement, period 2023-12-31 | 0001654954-24-005061 |
| 2024-04-04 | 12:10 ET | [8-K](/filings/0001654954-24-004239.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001654954-24-004239 |
| 2024-04-01 | 15:56 ET | [10-K](/filings/0001558370-24-004517.md) | Annual report, period 2023-12-31 | 0001558370-24-004517 |
| 2024-03-15 | 07:46 ET | [8-K](/filings/0001654954-24-003187.md) | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001654954-24-003187 |
| 2024-02-29 | 11:03 ET | [8-K](/filings/0001654954-24-002358.md) | 5.07 Shareholder vote results | 0001654954-24-002358 |
| 2024-01-17 | 07:45 ET | [DEF 14A](/filings/0001654954-24-000644.md) | Proxy statement, period 2024-01-16 | 0001654954-24-000644 |
| 2023-11-13 | 16:16 ET | [8-K](/filings/0001654954-23-014163.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001654954-23-014163 |
| 2023-11-13 | 16:11 ET | [10-Q](/filings/0001558370-23-018830.md) | Quarterly report, period 2023-09-30 | 0001558370-23-018830 |
| 2023-10-10 | 17:35 ET | [8-K](/filings/0001654954-23-012710.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001654954-23-012710 |
| 2023-09-14 | 17:58 ET | [8-K](/filings/0001654954-23-011829.md) | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001654954-23-011829 |
| 2023-09-06 | 08:18 ET | [8-K](/filings/0001654954-23-011572.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001654954-23-011572 |
| 2023-08-10 | 16:22 ET | [8-K](/filings/0001654954-23-010493.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001654954-23-010493 |
| 2023-08-10 | 16:05 ET | [10-Q](/filings/0001558370-23-014491.md) | Quarterly report, period 2023-06-30 | 0001558370-23-014491 |
| 2023-06-14 | 16:31 ET | [8-K](/filings/0001654954-23-008016.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001654954-23-008016 |
| 2023-05-11 | 16:27 ET | [8-K](/filings/0001654954-23-006220.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001654954-23-006220 |
| 2023-05-11 | 16:15 ET | [10-Q](/filings/0001558370-23-009389.md) | Quarterly report, period 2023-03-31 | 0001558370-23-009389 |
| 2023-05-11 | 08:00 ET | [8-K](/filings/0001654954-23-006129.md) | 1.01 Entry into a material agreement | 0001654954-23-006129 |
| 2023-05-09 | 08:57 ET | [8-K](/filings/0001654954-23-005950.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001654954-23-005950 |
| 2023-04-28 | 16:44 ET | [DEF 14A](/filings/0001654954-23-005420.md) | Proxy statement, period 2023-06-13 | 0001654954-23-005420 |
| 2023-03-17 | 16:15 ET | [8-K](/filings/0001654954-23-003129.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001654954-23-003129 |

Page 1 of 4. [Older](/companies/zomdf/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.